Clinical Trials Logo

Clinical Trial Summary

Hypothesis: Treatment with the hydrophilic coated valved intraurethral catheter up to 16 hours per day is effective, well tolerated and seemingly safe for treatment of women with stress incontinence. Test persons: Ten to twenty stress incontinent women. Treatment time: Up to two weeks


Clinical Trial Description

Demonstrate ease and comfort of device insertion, indwelling and removal. Patient acceptability during use. Other: - Symptom and QOL questionnaire. - Drop out analysis. - Is the patient motivated to continue using the valve catheter? - Is the patient motivated to recommend the valve catheter to other stress incontinent women? ;


Study Design


Related Conditions & MeSH terms


NCT number NCT06451796
Study type Observational
Source MagCath
Contact Dorthe Snejbjerg, MD Phd
Phone (+45) 44 94 12 12
Email info@gyncare.dk
Status Recruiting
Phase
Start date June 18, 2024
Completion date September 2024

See also
  Status Clinical Trial Phase
Completed NCT03727945 - Posture in Abdominopelvic Training in Women SUI N/A
Terminated NCT01673360 - Collection of Long Term Patient Outcomes Data Following Implantation of AMS Surgical Devices N/A
Completed NCT03682926 - Electrostimulation PROTOCOL Incontinence N/A
Completed NCT05207189 - Biological Sling Allograft (UVT) for the Treatment of Urinary Incontinence in Women Presenting With Synthetic Sling Complications Phase 2
Completed NCT01230450 - Feasibility of Comparing Two Surgical Treatment of Female Urodynamic Stress Phase 1
Recruiting NCT03996070 - VESPER: Stress Urinary Incontinence STUDY N/A
Recruiting NCT05448482 - Hybrid Versus Synthetic TOT for Treatment of SUI N/A
Completed NCT03106103 - Incidence of Symptomatic and Asymptomatic Bacteriuria After Urodynamic Study in Women N/A
Completed NCT03174431 - Continence Pessary Versus Disposable Intravaginal Device Trial N/A